Dr. Den Featured in ASCOPost: Genomic Test Identifies Patients With Prostate Cancer in Need of Intensified Salvage Therapy

Prostate cancer has been slow to catch up with breast cancer in terms of using biomarkers, but a new study represents progress in this regard. A genomic classifier called Decipher® provides important information that can be used to make treatment decisions for men with prostate cancer and a rising prostate-specific antigen (PSA) after radical prostatectomy. …


Sidney Kimmel Cancer Center Approved for a $250K Engagement Award by the Patient-Centered Outcomes Research Institute

[Philadelphia, PA]. (November 17, 2015) – A team at Thomas Jefferson University’s Sidney Kimmel Cancer Center has been approved for a Eugene Washington PCORI Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) to support the reduction of cancer disparities.   Ronald Myers, Ph.D., Director of the Division of Population Science will lead the engagement …


Examining the Cost of Cancer Treatment: Dr. Adam Dicker

Dr. Adam Dicker, a professor and chair of the Department of Radiation Oncology at Thomas Jefferson University’s Sidney Kimmel Cancer Center, was a coauthor of the ASCO guidelines. His research focuses on novel drugs, immunotherapy, and the application of precision medicine for patients with cancer. He recently spoke to us about the cost of cancer …


The Perfect Match Might Be the Imperfect One

When it comes to treating blood cancers like leukemia and lymphomas, new research shows that a half-matched donor bone marrow transplant may be just as good as a full match, in the first apples to apples type comparison of its kind. (PHILADELPHIA) – Bone marrow transplantation is a life-saving therapy for many patients with blood …


Dr. Robert Den featured in OncoTherapy Network

Genomic Classifier May Help Predict Metastasis Following Prostatectomy and SRT Clinicians may now have a better tool for guiding therapy in men with prostate cancer who have had a prostatectomy and salvage radiation therapy (SRT). Investigators calculated genomic classifier (GC) scores for 166 patients based on genomic analysis of their own tumor tissue. They found …


Dr. Robert Den featured in ASCO Post

For men with prostate cancer who have had a prostatectomy and salvage radiation therapy, analyzing their tumor genome provides clues as to whether their cancer will metastasize, thereby enabling clinicians to better personalize treatment options, according to research presented by Robert Den, MD.  ASTRO 2015: Genomic Classifier Appears to Predict Metastasis in Patients With Prostate …


SKCC Team Makes the NOCC Walk a Success

On September 12th, 2015 the Sidney Kimmel Cancer Team finished in 8th place out of 130 fundraising teams that participated in National Ovarian Cancer Coalition walk.  The SKCC team led by Trish Wright, RN, Amanda Jackson NP, Samantha Schaffer MA, and Charlene Appenzeller represented the Sidney Kimmel Cancer Center in helping the mission of the …


Genomic Analysis for All Cancer Patients

09/17/15 Jefferson expands its cancer treatment to analyze each cancer patient’s tumor with the newest techniques and help doctors identify cutting edge treatment options. (PHILADELPHIA) – Cancer medicine is moving towards understanding what drives each particular patient’s cancer. But not every patient has had access to this level of individualized care. Today, Jefferson announced its …

Page 1 of 18